arrow
M

Mark A. Brockman

Murdoch University
H指数:50
被引数:8,397

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Twelve-month trajectories of depressive symptoms and associated socio-structural factors among adolescents and young adults in Soweto and Durban, South Africa

南非索韦托和德班地区青少年和年轻成年人抑郁症状的12个月轨迹及其相关的社会结构因素

2025-10-100
PRE
T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy
2024-04-242
OAAI
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

HIV感染者突破性SARS-CoV-2感染的相关性: CIHR CTN 328研究的结果

2024-04-231
OAAI
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity
2024-04-016
OAAI
Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
AIDS
IF3.1
2024-01-226
OA
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada

加拿大HIV感染者接种冠状病毒疾病2019疫苗后的抗体中和能力

AIDS
IF3.1
2023-08-034
OAAI
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
2023-02-092
OAAI
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

接受抑制性抗逆转录病毒治疗的HIV感染者接受三剂冠状病毒疾病2019疫苗接种后的抗体反应耐久性

AIDS
IF3.1
2022-12-2216
OAAI
COVID-19 vaccine immunogenicity in people with HIV

新型冠状病毒肺炎疫苗在HIV感染者中的免疫原性

AIDS
IF3.1
2022-11-1825
OAAI
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
2022-09-064
OAAI
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

接受抑制性抗逆转录病毒治疗的人类免疫缺陷病毒在双重冠状病毒疾病2019疫苗接种和强烈的第三剂量反应后显示出典型的抗体持久性

2022-06-0735
OAAI
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose
2022-05-1124
OAAI
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

接受抑制性抗逆转录病毒治疗的HIV感染者对新型冠状病毒肺炎疫苗接种的体液免疫反应

2022-02-2865
OAAI
The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation
2021-12-3016
OAAI
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
2021-12-0972
OAAI